What's behind Astera Labs's latest stock surge?

Traders Union
All News
Stocks
Astera Labs rises 2.59% today

Highlights

Astera Labs posted record third-quarter revenue of $584.9 million, a 154% increase year over year, and projects fourth-quarter revenue of $730 million to $750 million.
The company is expanding its Scorpio X-Series and P-Series AI connectivity product lines, with ongoing production shipments reported.
Shares of Astera Labs trade below key moving averages as technical indicators remain firmly oversold and the next five-session forecast range is $147.3 to $220.94, with a high likelihood of further declines if support at $180.21 breaks.

Record revenue and leadership change drive bullish sentiment

Astera Labs reported record third-quarter 2026 revenue of $584.9 million, up 154% year over year, and projected fourth-quarter revenue between $730 million and $750 million as demand for its AI connectivity products remains strong. The company highlighted ongoing production shipments of its Scorpio X-Series and the expansion of its P-Series lineup. Michael Hurlston resigned from the board effective November 3, 2026.

Anton Kharitonov, expert at Traders Union, views Astera Labs' rebound as technically weak and sentiment-driven. He points to the stock trading below all major moving averages despite record revenue and guidance, which signals broader distrust in the rally. Kharitonov notes momentum remains negative, with most oscillators in oversold yet price action unable to establish a clear reversal amid leadership uncertainty after the board resignation. He cautions that heavy intraday selling and narrowly defined support levels create risk for further downside. "Despite the positive headlines, I see little to justify aggressive buying here until price reclaims key averages and sellers lose control," Kharitonov states.

Viktoras Karapetjanc, expert at Traders Union, remains constructive on Astera Labs following record-setting results and robust sales outlook. He highlights the company's sustained demand for AI connectivity and strong fourth-quarter guidance as long-term growth catalysts. Karapetjanc notes the bullish structure remains intact, with the 50-day average above the 200-day. "I believe the fundamentals and market position lay groundwork for further growth — a close above $195.36 could trigger renewed upside momentum," says Karapetjanc.

Jainam Mehta, market strategist, takes a scenario-based approach to Astera Labs’ outlook. He observes heightened volatility and weak momentum indicators, while also recognizing deeply oversold readings which may invite tactical rebounds. Mehta identifies a potential breakout setup above $195.36 or renewed weakness if $180.21 fails. "Traders should watch for sharp intraday reversals or a volatility-driven squeeze as positioning remains one-sided," comments Mehta.

Oversold momentum signals rebound risk as trend structure holds

Astera Labs is trading below its 20-day, 50-day, and 200-day moving averages ($275.64, $302.71, and $255.98), reflecting downward pressure across all trend horizons. Short-term support is identified at $180.21 and resistance at $195.36. The 50-day average remains above the 200-day, confirming a bullish long-term structure. Momentum is weak according to the MACD and ADX, with the RSI, Stochastic RSI, and CCI all in oversold territory, suggesting conditions that could lead to a potential rebound. Intraday, sellers dominate as indicated by the Bull/Bear Power, and the Awesome Oscillator maintains a bearish tone. Despite an upside gap and brief bounce, the price has moved lower toward session lows, with volatility at 8.41%.

Earlier, analysts noted that Astera Labs remained a key player in AI infrastructure despite recent weakness in its stock performance. With current price action signaling a heightened risk of further downside, traders should monitor $180.21 as a critical support level that could define the near-term outlook.

Source of Data: ALAB Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.